全文获取类型
收费全文 | 25710篇 |
免费 | 1798篇 |
国内免费 | 169篇 |
专业分类
耳鼻咽喉 | 204篇 |
儿科学 | 575篇 |
妇产科学 | 472篇 |
基础医学 | 3667篇 |
口腔科学 | 259篇 |
临床医学 | 2309篇 |
内科学 | 6057篇 |
皮肤病学 | 329篇 |
神经病学 | 2529篇 |
特种医学 | 862篇 |
外国民族医学 | 1篇 |
外科学 | 4772篇 |
综合类 | 161篇 |
一般理论 | 9篇 |
预防医学 | 1574篇 |
眼科学 | 286篇 |
药学 | 1546篇 |
中国医学 | 77篇 |
肿瘤学 | 1988篇 |
出版年
2023年 | 120篇 |
2022年 | 243篇 |
2021年 | 489篇 |
2020年 | 360篇 |
2019年 | 596篇 |
2018年 | 649篇 |
2017年 | 492篇 |
2016年 | 537篇 |
2015年 | 631篇 |
2014年 | 887篇 |
2013年 | 1209篇 |
2012年 | 1815篇 |
2011年 | 1960篇 |
2010年 | 1192篇 |
2009年 | 1123篇 |
2008年 | 1719篇 |
2007年 | 1765篇 |
2006年 | 1653篇 |
2005年 | 1730篇 |
2004年 | 1526篇 |
2003年 | 1550篇 |
2002年 | 1575篇 |
2001年 | 232篇 |
2000年 | 192篇 |
1999年 | 261篇 |
1998年 | 338篇 |
1997年 | 321篇 |
1996年 | 225篇 |
1995年 | 218篇 |
1994年 | 174篇 |
1993年 | 172篇 |
1992年 | 140篇 |
1991年 | 122篇 |
1990年 | 115篇 |
1989年 | 90篇 |
1988年 | 87篇 |
1987年 | 67篇 |
1986年 | 101篇 |
1985年 | 85篇 |
1984年 | 90篇 |
1983年 | 91篇 |
1982年 | 100篇 |
1981年 | 90篇 |
1980年 | 88篇 |
1979年 | 55篇 |
1978年 | 45篇 |
1977年 | 37篇 |
1976年 | 37篇 |
1975年 | 35篇 |
1974年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
991.
Pierre Bourgoin Aicha Merouani Véronique Phan Catherine Litalien Michel Lallier Fernando Alvarez Philippe Jouvet 《Pediatric nephrology (Berlin, Germany)》2014,29(5):901-908
Background
Supportive care as a bridge to transplant or recovery remains challenging in children suffering from acute liver failure (ALF). We report our experience in children using the Molecular Absorbent Recirculating System (MARS®).Methods
Retrospective data from children receiving therapy using MARS® from October 2009 to October 2012 were included in this single-center retrospective study. Patient characteristics, clinical presentation and complications of ALF, clinical and biological data before and after each MARS® session, technical modalities and adverse events were recorded.Results
A total of six children underwent 17 MARS® sessions during the study period. Two adolescents were treated with the adult filter MARSFLUX® and four infants were treated with the MiniMARS® filter. The mean PEdiatric Logistic Dysfunction (PELOD) score at admission was 19 (range 11–33). All patients were mechanically ventilated, and four had acute kidney injury. The neurological course improved in one case, judged as stable in two cases and worsened in one case; data were unavailable in two cases. Mean serum ammonia levels decreased significantly following treatment with MARS® from an initial 89?±?29 to 58?±?35 mcmol/L (p?=?0.02). No other significant biological improvement was observed. Hemodynamic status improved/remained unchanged in the adolescent group, but in the infants four of the seven sessions were poorly tolerated and two sessions were aborted. Three patients died, two were successfully transplanted and one recovered without transplantation.Conclusion
In our experience, treatment with MARS® is associated with encouraging results in adolescents, but it needs modification for very sick infants to improve tolerance. 相似文献992.
Theresa Neimert-Andersson Jonas Binnmyr Mattias Enoksson Joakim Langebäck Louise Zettergren Anne-Charlotte Hällgren Henry Franzén Sara Lind Enoksson Pierre Lafolie Alf Lindberg Nabil Al-Tawil Mats Andersson Peter Singer Hans Grönlund Guro Gafvelin 《Vaccine》2014
ViscoGel, a chitosan-based hydrogel, has earlier been shown to improve humoral and cell-mediated immune responses in mice. In this study, a Phase I/IIa clinical trial was conducted to primarily evaluate safety and secondarily to study the effects of ViscoGel in combination with a model vaccine, Act-HIB to Haemophilus influenzae type b, administered as a single intramuscular injection. Healthy volunteers of both sexes, ages 22–50 and not previously vaccinated to HIB, were recruited. The trial had two phases. In Phase A, three ascending dose levels of ViscoGel (25, 50 and 75 mg) were evaluated for safety in 3 × 10 subjects. Phase B had a single-blind, randomised, parallel-group design evaluating safety and efficacy in five groups, 20 subjects/group, comparing vaccination with 0.2 μg or 2 μg Act-HIB alone or combined with ViscoGel (50 mg) and one group receiving the standard Act-HIB dose (10 μg). No safety or tolerability concerns were identified. Local, transient reactions at the injection site were the most common adverse events. These were more frequent in groups receiving Act-HIB + ViscoGel, while other AEs were recorded at similar frequency in Act-HIB and Act-HIB + ViscoGel groups. Efficacy was evaluated by measuring serum anti-HIB antibodies and cellular responses in peripheral blood mononuclear cells (PBMC). There was a large variation in baseline anti-HIB antibody titres and no adjuvant effect was observed on the anti-HIB antibody production in groups vaccinated with Act-HIB + ViscoGel. ELISpot analyses revealed increased interferon-γ (IFN-γ) responses to Act-HIB in PBMCs from subjects vaccinated with Act-HIB in combination with ViscoGel, compared to groups receiving Act-HIB alone. Moreover, ViscoGel counteracted an inhibitory effect of Act-HIB vaccination on the IFN-γ response to both the vaccine itself and an irrelevant influenza antigen. In summary, ViscoGel was found to be safe and well-tolerated, supporting further examination of ViscoGel as a new innovative vehicle for vaccine development. 相似文献
993.
Healthcare students are a specific subgroup of healthcare workers as they are often not identified by the occupational medicine systems in healthcare facilities, because of their shared time between hospital wards and universities. Nevertheless, they should comply with the same vaccination recommendations as employed healthcare workers because they are in close and repeated contact with patients. Occupational immunization recommendations may vary between countries, but always include vaccine-preventable diseases that might lead to nosocomial outbeaks and/or fatal outcomes for healthcare workers or patients. Studies conclude that vaccine coverage is too low in healthcare students, and that they are often not aware of their possibility to be vectors of infections to frail patients. Efforts should be made to educate medical and nursing students on vaccines, to convince them of the utility of immunization and to offer them an increased access to occupational vaccinations in hospitals and universities. 相似文献
994.
Elisabeth Favre Antoine Daina Pierre‐Alain Carrupt Alessandra Nurisso 《Chemical biology & drug design》2014,84(2):206-215
Tyrosinases are type 3 copper proteins involved in melanin biosynthesis, responsible for skin and hair color in mammals. To steer tyrosinase inhibitor discovery for therapeutic and cosmetic purposes, structural information about human tyrosinase is necessary. As this protein has never been crystallized so far, we derived a robust homology model built using structural information from Streptomyces castaneoglobisporus and Ipomea batata catecholoxidase enzymes. The active site containing two copper atoms in co‐ordination with six histidine residues was refined through an optimization protocol based on molecular mechanics parameters for copper co‐ordination and charges calculated by quantum mechanics methods. Five structural water molecules and a hydroxyl ion were found to be essential for optimization. The superimposition of the human homology model on crystallographic structures of tyrosinases from other species revealed similar overall backbone topologies, active site conformations, and conserved water molecules. Phenylthiourea (PTU), the tyrosinase inhibitor of reference, was then docked into the solvated human active pocket. A binding mode consistent with crystallographic information was obtained. Taken together, these findings demonstrated that the human tyrosinase model, deposited in the Protein Model Database, is a reliable structure for future rational inhibitor design projects. 相似文献
995.
Charlotte Dufour Romain Perbet Pierre Leblond Romain Vasseur Laurence Stechly Adeline Pierache Nicolas Reyns Gustavo Touzet Emilie Le Rhun Matthieu Vinchon Claude‐Alain Maurage Fabienne Escande Florence Renaud 《Brain pathology (Zurich, Switzerland)》2020,30(1):179-190
Pediatric diffuse midline gliomas are devastating diseases. Among them, diffuse midline gliomas H3K27M‐mutant are associated with worse prognosis. However, recent studies have highlighted significant differences in clinical behavior and biological alterations within this specific subgroup. In this context, simple markers are needed to refine the prognosis of diffuse midline gliomas H3K27M‐mutant and guide the clinical management of patients. The aims of this study were (i) to describe the molecular, immunohistochemical and, especially, chromosomal features of a cohort of diffuse midline gliomas and (ii) to focus on H3K27M‐mutant tumors to identify new prognostic markers. Patients were retrospectively selected from 2001 to 2017. Tumor samples were analyzed by immunohistochemistry (including H3K27me3, EGFR, c‐MET and p53), next‐generation sequencing and comparative genomic hybridization array. Forty‐nine patients were included in the study. The median age at diagnosis was 9 years, and the median overall survival (OS) was 9.4 months. H3F3A or HIST1H3B mutations were identified in 80% of the samples. Within the H3K27M‐mutant tumors, PDGFRA amplification, loss of 17p and a complex chromosomal profile were significantly associated with worse survival. Three prognostic markers were identified in diffuse midline gliomas H3K27M‐mutant: PDGFRA amplification, loss of 17p and a complex chromosomal profile. These markers are easy to detect in daily practice and should be considered to refine the prognosis of this entity. 相似文献
996.
Alexandre Janin Valrie Chanavat Pierre‐Antoine Rollat‐Farnier Claire Bardel Karine Nguyen Philippe Chevalier Jean‐Christophe Eicher Laurence Faivre Juliette Piard Emma Albert Severine Nony Gilles Millat 《Human mutation》2020,41(2):465-475
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, historically believed to affect 1 of 500 people. MYBPC3 pathogenic variations are the most frequent cause of familial HCM and more than 90% of them introduce a premature termination codon. The current study aims to determine the prevalence of deep intronic MYBPC3 pathogenic variations that could lead to splice mutations. To improve molecular diagnosis, a next‐generation sequencing (NGS) workflow based on whole MYBPC3 sequencing of a cohort of 93 HCM patients, for whom no putatively causative point mutations were identified after NGS sequencing of a panel of 48 cardiomyopathy‐causing genes, was performed. Our approach led us to reconsider the molecular diagnosis of six patients of the cohort (6.5%). These HCM probands were carriers of either a new large MYBPC3 rearrangement or splice intronic variations (five cases). Four pathogenic intronic variations, including three novel ones, were detected. Among them, the prevalence of one of them (NM_000256.3:c.1927+ 600 C>T) was estimated at about 0.35% by the screening of 1,040 unrelated HCM individuals. This study suggests that deep MYBPC3 splice mutations account for a significant proportion of HCM cases (6.5% of this cohort). Consequently, NGS sequencing of MYBPC3 intronic sequences have to be performed systematically. 相似文献
997.
Daniel Candotti Virginie Sauvage Pierre Cappy Mohamed Abdallahi Boullahi Pascal Bizimana Guy Olivier Mbensa Sekou Oumar Coulibaly Aimée Olivat Rakoto Alson Hadiza Soumana Claude Tagny-Tayou Edward L. Murphy Syria Laperche for The Francophone Africa Transfusion Research Network 《Transfusion》2020,60(1):106-116
998.
Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in french women with poor adhesion to regular cervical screening
下载免费PDF全文
![点击此处可从《Journal of medical virology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
999.
1000.
Comparison of EBV DNA viral load in whole blood,plasma, B‐cells and B‐cell culture supernatant
下载免费PDF全文
![点击此处可从《Journal of medical virology》网站下载免费的PDF全文](/ch/ext_images/free.gif)